Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term ad [Administration & Dosage]. Found 9 abstracts

Meropol NJ, Gold PJ, Diasio RB, Andria M, Dhami M, Godfrey T, Kovatich AJ, Lund KA, Mitchell E, Schwarting R. Thymidine phosphorylase expression is associated with response to capecitabine plus irinotecan in patients with metastatic colorectal cancer.[see comment]. Journal of Clinical Oncology. 2006 Sep;24(25):4069-77.
Narra K, Borghaei H, Al-Saleem T, Hoglund M, Smith MR. Pure red cell aplasia in B-cell lymphoproliferative disorder treated with rituximab: report of two cases and review of the literature. Leukemia Research. 2006 Jan;30(1):109-14.
Adams GP, Shaller CC, Dadachova E, Simmons HH, Horak EM, Tesfaye A, Klein-Szanto AJ, Marks JD, Brechbiel MW, Weiner LM. A single treatment of yttrium-90-labeled CHX-A"-C6.5 diabody inhibits the growth of established human tumor xenografts in immunodeficient mice.[see comment]. Cancer Research. 2004 Sep;64(17):6200-6.
Badawi AF, Eldeen MB, Liu Y, Ross EA, Badr MZ. Inhibition of rat mammary gland carcinogenesis by simultaneous targeting of cyclooxygenase-2 and peroxisome proliferator-activated receptor gamma. Cancer Research. 2004 Feb;64(3):1181-9.
Gallo JM, Vicini P, Orlansky A, Li S, Zhou F, Ma J, Pulfer S, Bookman MA, Guo P. Pharmacokinetic model-predicted anticancer drug concentrations in human tumors. Clinical Cancer Research. 2004 Dec;10(23):8048-58.
Langer CJ. Irinotecan in advanced lung cancer: focus on North American trials. Oncology (Huntington). 2004 Jun;18(7 Suppl 4):17-28.
Stoyanova R, Nicholson JK, Lindon JC, Brown TR. Sample classification based on Bayesian spectral decomposition of metabonomic NMR data sets. Analytical Chemistry. 2004 Jul;76(13):3666-74.
Uzzo RG, Brown JG, Horwitz EM, Hanlon A, Mazzoni S, Konski A, Greenberg RE, Pollack A, Kolenko V, Watkins-Bruner D. Prevalence and patterns of self-initiated nutritional supplementation in men at high risk of prostate cancer. BJU international. 2004 May;93(7):955-60.
Sasson AR, Wetherington RW, Hoffman JP, Ross EA, Cooper H, Meropol NJ, Freedman G, Pingpank JF, Eisenberg BL. Neoadjuvant chemoradiotherapy for adenocarcinoma of the pancreas: analysis of histopathology and outcome. International Journal of Gastrointestinal Cancer. 2003 Jan;34(2-3):121-8.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term ad [Administration & Dosage]

ad [Administration & Dosage] aa [Analogs & Derivatives] Female Male dt [Drug Therapy] me [Metabolism] Middle Aged Antineoplastic Combined Chemotherapy Protocols Rats tu 0 (Antineoplastic Combined Chemotherapy Protocols) Adult Aged pa [Pathology] Non-US Gov't Research Support [Therapeutic Use] 951-77-9 (Deoxycytidine) Deoxycytidine Camptothecin bi [Biosynthesis] Survival Analysis pc [Prevention & Control] Human ai [Antagonists & Inhibitors] Fluorouracil Predictive Value of Tests 7689-03-4 (Camptothecin) Comparative Study 80 and over Aged 51-21-8 (Fluorouracil) Antineoplastic Agents 103882-84-4 (gemcitabine) Ovarian Neoplasms en [Enzymology] 0 (Antineoplastic Agents) pd [Pharmacology] 100286-90-6 (irinotecan) rt [Radiotherapy] de [Drug Effects] Dihydrouracil Dehydrogenase (NADP) Computer Simulation N' -N-N'-N''-N''-pentaacetic acid) 41575-94-4 (Carboplatin) 363-24-6 (Dinoprostone) Prostaglandin D2 EC 1-17-4 (Ribonucleotide Reductases) ur [Urine] Monoclonal Antibodies tu [Therapeutic co [Complications] Neoadjuvant Therapy 0 (Sesquiterpenes) 2-diamine (N-(2-amino-3-(4-isothiocyanatophenyl)propyl)cyclohexane-1 ri [Radionuclide Imaging] Enzymologic Gene Expression Regulation Colorectal Neoplasms Xenograft Model Antitumor Assays Pure Red-Cell Aplasia Wistar Rats EC 1-14-99-1 (Prostaglandin-Endoperoxide Synthase) Apoptosis 154361-50-9 (capecitabine) EC 2-4-2-4 (Thymidine Phosphorylase) 61-90-5 (Leucine) Phytogenic) 0 (Antineoplastic Agents Biological) 0 (Tumor Markers Prostaglandin-Endoperoxide Synthase mt [Methods] Drug Toxicity SCID Mice Monoclonal) 0 (Antibodies 0 (Isothiocyanates) Thymidylate Synthase Lymphoma Lung Neoplasms cl [Classification] 129298-91-5 (O-(chloroacetylcarbamoyl)fumagillol) Cell Cycle Effects] Carboplatin Topotecan 85622-93-1 (temozolomide) Anticarcinogenic Agents Non-US Gov't Support 0 (Hydrazines) Small Cell Carcinoma pk [Pharmacokinetics] Bayes Theorem Cytoplasmic and Nuclear) 0 (Receptors 0 (Carcinogens) 0 (Taxoids) 67-43-6 (Pentetic Acid) ag [Agonists] Drug Dose-Response Relationship Fluorenes pk im [Immunology] ae [Adverse EC 2-1-1-45 (Thymidylate Synthase) Immunotoxins Radioimmunotherapy 169590-42-5 (celecoxib) Vitamins Vascular Endothelial Growth Factor A Databases Reproducibility of Results 123948-87-8 (Topotecan) 0 (Cyclooxygenase Inhibitors) erbB-2) EC 2-7-1-112 (Receptor Risk Factors 33419-42-0 (Etoposide) su [Surgery] Drug Synergism 0 (Immunoglobulin Variable Region) 0 (Vascular Endothelial Growth Factor A) 684-93-5 (Methylnitrosourea) Herbal Medicine Cisplatin Dietary Supplements 4342-03-4 (Dacarbazine) Isothiocyanates 0 (Yttrium Radioisotopes) Breast Neoplasms Inbred F344 Rats Lymphocytic Leukemia-Chronic [Pharmacokinetics] Non-Small-Cell Lung Carcinoma Nude Rats Pentetic Acid Pancreatectomy Carcinogens Immunohistochemistry 35661-60-0 (N-(fluorenyl-9-methoxycarbonyl)leucine) Experimental Mammary Neoplasms Proportional Hazards Models Dacarbazine 0 (Fluorenes) Pancreatic Neoplasms Taxoids Dinoprostone 0 (15-deoxyprostaglandin J2) Prostatic Neoplasms Yttrium Radioisotopes Nude Mice Biological Models 50-07-7 (Mitomycin) Sesquiterpenes Fibrosis et [Etiology] Liver
Last updated on Wednesday, February 05, 2020